| Code | 6926E | ||||||||||
| MA number | 15/0186/24-S | ||||||||||
| Product Form: | plo ijf 1x1 g (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olikla s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.07.2024 |
| Validity: | 29.07.2029 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Ceftazidime Olikla plo ijf_04_2025.pdf
|
| SPC: |
SPC_Ceftazidime Olikla plo ijf_04_2025.pdf
|
| Safety feature | Yes |
| Data update: | 30.07.2024 |
